About
Doug Levinson is a Co-Founder and CEO at Fount Bio, Inc. Doug joined Flagship in 2006, bringing to Flagship�s venture investment and new venture creation activities over fifteen years of experience in the biotech industry. Prior to Flagship, Doug was with TransForm Pharmaceuticals since 2000 as part of its scientific founding team joining Professors Bob Langer and Michael Cima of MIT. Most recently, he was Vice President of Emerging Science and Technology and led the design, development, and implementation of TransForm's basic technology platforms and business model. TransForm was acquired by Johnson & Johnson for $230 million in 2005. Prior to TransForm, Doug was with Millennium Pharmaceuticals, which he joined as a founding scientific team member. At Millennium for seven years, Doug was responsible for establishing the company's early scientific program in Immunology/Inflammation, which he grew to the largest research effort at Millennium with a staff of 170 researchers. Before jo
Position in the VCSift Database
- • 927 investors hold the Co-Founder and CEO role in VCSift. Doug Levinson is one of them.
- • 2,293 investors are based in Boston, Massachusetts, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Boston, US
Contact Information
Find more investors like Doug
Search Investors